Atmaram P Pawar
Overview
Explore the profile of Atmaram P Pawar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patil P, Suryawanshi S, Patil S, Pawar A
J Taibah Univ Med Sci
. 2024 Apr;
19(2):252-262.
PMID: 38616800
Objectives: Antibiotics are the most commonly administered medications among pediatric patients. However most of the time, accurate dose administration to children becomes a problem due to the extremely bitter taste....
2.
Patil P, Pawar A, Mahadik K, Gaikwad V
Expert Opin Drug Deliv
. 2021 Nov;
18(12):1843-1855.
PMID: 34814778
Introduction: Bioequivalence is established by comparing the bioequivalence study results of generic drugs with the reference listed drug. Several global regulatory agencies have published the guidance for locally acting orally...
3.
Ahiwale R, Chellampillai B, Pawar A
AAPS PharmSciTech
. 2020 Oct;
21(7):279.
PMID: 33037507
This study aimed at carrying out a preformulation investigation of nanocochleates (NCs) and develop andrographolide-loaded nanocochleates. Preformulation study comprised of exploring the effect of trivalent and divalent ions on transition...
4.
Gaikwad V, Jadhav N, Pawar A, Mahadik K
AAPS PharmSciTech
. 2019 May;
20(5):192.
PMID: 31115715
The number of unit operations to be followed in the preparation of tablets was cumbersome and may introduce material as well as process-related critical parameters which may negatively affect the...
5.
Mali A, Pawar A, Purohit R
J Pharm (Cairo)
. 2015 Nov;
2014:795371.
PMID: 26556201
The progress in the development of DPI technology has boosted the use of sensitive drug molecules for lung diseases. However, delivery of these molecules from conventional DPI to the active...
6.
Pawar A, Gholap A, Kuchekar A, Bothiraja C, Mali A
J Drug Deliv
. 2015 Mar;
2015:261068.
PMID: 25789176
Background. Oxybenzone, a broad spectrum sunscreen agent widely used in the form of lotion and cream, has been reported to cause skin irritation, dermatitis, and systemic absorption. Aim. The objective...
7.
Bothiraja C, Gholap A, Shaikh K, Pawar A
Ther Deliv
. 2014 Oct;
5(7):781-94.
PMID: 25287385
Background: The aim of the study was to investigate ethyl cellulose microsponges as topical carriers for the controlled release and cutaneous drug deposition of eberconazole nitrate (EB). Materials & Method:...
8.
Bothiraja C, Yojana B, Pawar A, Shaikh K, Thorat U
Expert Opin Drug Deliv
. 2013 Dec;
11(1):17-29.
PMID: 24294925
Background: The natural flavonoid fisetin has shown anticancer properties but its in vivo administration remains challenging due its poor aqueous solubility and extensive in vivo metabolism. This juncture demands an...
9.
Bothiraja C, Kapare H, Pawar A, Shaikh K
Ther Deliv
. 2013 Oct;
4(10):1247-59.
PMID: 24116910
Background: Phospholipid and Tween(®) 80 mixed micelles were investigated as injectable nanocarriers for the natural anticancer compound, plumbagin (PBG), with the aim to improve anticancer efficiency. PBG-loaded mixed micelles were...
10.
Bothiraja C, Pawar A, Dama G, Joshi P, Shaikh K
J Pharmacol Toxicol Methods
. 2012 Jun;
66(1):35-42.
PMID: 22652081
Introduction: Various shortcomings of the available methods of extraction of plumbagin from Plumbago zeylanica using non-edible organic solvents coupled with the poor aqueous solubility and low bioavailability called for extracting...